Oncology information system is an image and information management system that allows to check all parts of oncology care for patients. Oncology information system combines medical, surgical, and radiation oncology information into a comprehensive, oncology electronic medical record that allows to manage patient’s details from start of the patient’s admission through diagnosis and follow-up details.
The factors driving the growth of the oncology information system market are increase in technological adaption and technological advancement. Increase in health care infrastructure in developing nations, growth in prevalence of secondary tumor, and rise in incidence of cancer are the other factors anticipated to propel the growth of the oncology information system market during the forecast period. According to the National Cancer Institute, cancer is among the leading causes of death worldwide; in 2012, there were 14 million new cases and 8.2 million cancer-related deaths worldwide. However, lack of health care IT professionals and strict regulation are likely to restrict the growth of the oncology information system market.
Browse Global Strategic Business Report:
According to a report by the American Cancer Society, 50% of men and 30% of women are estimated to develop cancer in some form or the other in their lifetime. Increase in amount of cancer patients is a major driver of the sales of the oncology information system market. Additionally, rise in amount of tobacco consumption and increase in amount of carcinogens present in the polluted air or in any other form are projected to drive the oncology information system market in the near future. Some of the factors driving the growth of the market are rising disposable income, which enables patients to avail expensive treatments, easily available medical insurance policies, and growing medical tourism activities. Heavy investments in R&D further act as an opportunity for the growth of the market since innovative and technologically advanced products always have the capability of substituting its predecessors.
The oncology information system market has been segmented by product, application, end-user, and geography. Based on product, the oncology information system market is classified into patient information system, treatment planning system, consulting/optimization, implementation, maintenance, services, and others. Based on application, the market is segmented into care management, treatment management, and knowledge management. Based on end-user, the oncology information system market is segmented into hospital, government institution, research center, and others.
Geographically, the oncology information system market in segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to account for a large market share in terms of revenue, followed by Europe. The oncology information system market in North America is expected to grow due to technological advancement and increase in demand for advanced product. The growing need to implement advanced systems in the health care sector in the region and, at the same time, deliver quality care to patients are the factors likely to drive the market in the near future. Asia Pacific is expected to rise at a high CAGR owing to increase in adoption of technological advanced products, growth in disposable income, and rise in health care infrastructure in countries such as India, China, Australia, and other countries in the region. The Latin America oncology information system market is mainly driven by the increasing adoption of technological products in countries such as Brazil and Mexico. The Middle East & Africa oncology information system market is estimated to grow in the near future due to rise in incidence of cancer. According to World Health Organization, women in the African region had the highest incidence of cancer of the cervix uteri.
Major players operating in this market include CureMD Healthcare, Varian Medical Systems, Inc., Flatiron Health, Inc., Epic Systems Corporation, Bogardus Medical Systems, Inc., Cerner Corporation, McKesson Corporation, Koninklijke Philips N.V., Elekta AB, and Accuray Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Download Exclusive Brochure of This Report :
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact